萌学园

China's pharmaceutical industry sees accelerated innovation breakthroughs in H1_我的网站

A | 据外媒报道，Wi-Fi联盟已启动支持Wi-Fi 6标准的设备认证计划，预计将于今年第三季度启动。

B | 该计划适用于基于IEEE 802.11ax技术的设备，该技术于去年10月被Wi-Fi联盟指定为Wi-Fi 6，以简化不同代Wi-Fi技术的命名方案，并使消费者更容易接受和理解。 (ECNS) -- China's pharmaceutical industry accelerated innovation in the first half of this year, with domestic companies steadily improving their R&D capabilities and growth momentum continuing to strengthen, data showed. China's first broad-spectrum targeted anticancer drug entered clinical use at major hospitals across the country this year. It took only eight months to go from submission to market approval. A total of 38 innovative drugs were approved for marketing in China in the first half, of which 31 were developed domestically, more than 80% of the total. Eleven drugs featuring new targets or new mechanisms were all developed independently by domestic companies, producing a number of world-first innovations. By the end of 2025, China had 4,751 innovative drugs under development, one-third of the global total and the largest pipeline of any country. Behind this concentration of results lies a steadily strengthening industrial base. China has a complete pharmaceutical supply chain. It is not only the world's largest producer of active pharmaceutical ingredients but has also built a production system covering every pharmaceutical category. This year, digital, intelligent, and green technologies have driven the industry's transformation and upgrading. At a biopharmaceutical company in Shanxi Province, a newly built AI-powered bio-computing center can identify the structures of millions of protein functional domains in a short time, screening out ineffective molecules directly. To date, China has supported 21 pharmaceutical firms in building excellent-level smart factories and has cultivated more than 300 green factories. In the first half, the added value of pharmaceutical enterprises above the designated scale grew 6.4% year on year, and exports held strong. The world's first chemotherapy-sparing drug for gastric cancer, launched this year, had already earned overseas revenue through licensing deals before it reached the market, and is now exported to multiple countries and regions. In the first half, the total value of China's innovative drug out-licensing deals reached $110 billion, the industry's export delivery value grew 9% year on year, and high-value-added products made up nearly 20% of the total. (By Tang Yuxian) 。该认证计划被称为Wi-Fi认证6，旨在确保基于新一代Wi-Fi技术构建的设备符合互操作性和安全性行业标准。根据Wi-Fi联盟，该认证方案将为用户提供播放超高清电影甚至关键业务应用程序所需的容量、覆盖范围和性能。Wi-Fi认证6支持MU-MIMO、波束形成和1024-Quam技术带来的更高数据传输速率和更大网络容量等先进功能。其他功能包括改善拥挤环境中的性能，以及使用目标唤醒时间（twt）来提高电池寿命和实现更高的效率。ABI Research的高级研究分析师安德鲁·齐格纳尼（AndrewZignani）在一份声明中说：“Wi-Fi仍然是接入互联网的主要技术，并且有着悠久的成功历史。Wi-Fi认证6将进一步增强Wi-Fi的作用。预计2022年Wi-Fi 6芯片组的出货量将超过10亿。据了解，包括Ruckus、Huawei、Engenius、Charter、NEC、H3C、Calix、KT和Netgear在内的公司已宣布将提供基于高通Wi-Fi 6技术网络平台的相关产品和设备。